MHY-1685 是新型的mTOR抑制剂，在改善基于 hCSC 的心肌再生中有研究价值提供了机会。

MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.

27406-31-1

C11H8N2O4

232.19

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years